39 citations
,
January 1980 in “Dermatology” In this study, cyproterone acetate with ethinyl estradiol effectively treated acne, hirsutism, and alopecia in women, with the highest success in acne and rare side effects similar to estrogen contraceptives.
August 2023 in “International Journal of Women's Dermatology” In this study, a case of a 70-year-old woman with central centrifugal cicatricial alopecia showed that using a high-quality hair prosthesis improved her quality of life and mood, as measured by PHQ-9 and Skindex-29 scores, though such wigs are rarely covered by insurance.
1 citations
,
March 2020 in “International journal of reproduction, contraception, obstetrics and gynecology” In this study, hirsutism was the most prevalent skin manifestation among women with PCOS, and a significant association was observed between certain skin changes and hormonal abnormalities such as insulin resistance and elevated prolactin levels.
May 2016 in “Endocrine Abstracts” Proximal hair cortisol is a reliable tool for diagnosing Cushing's Syndrome.
July 2026 in “Frontiers in Public Health” This review highlights the inconsistent and often insufficient global coverage of cranial prostheses for medical hair loss, with variations depending on healthcare system models and a general lack of standardized recognition as medically necessary devices.
January 2024 in “ASEAN Journal of Psychiatry” In this study, researchers in Baghdad observed that women with PCOS who tested positive for CagA-IgG, a marker for H. pylori infection, showed significantly elevated insulin resistance and fasting blood sugar levels, regardless of metformin treatment, compared to controls.
This review discusses the diagnostic criteria and management challenges for polycystic ovarian syndrome and reports no clinical results, highlighting complications associated with pregnancy in women with the condition.
1 citations
,
January 2017 in “Indian Journal of Pharmaceutical Sciences” This study found that women with polycystic ovary syndrome in South India had higher body mass index, waist/hip ratio, and elevated levels of several hormones compared to controls, and waist/hip ratio may be a better risk indicator than body mass index.
July 2024 in “Journal of Investigative Dermatology” Human hair follicles have their own thyroid hormone system.
October 2024 in “Journal of the Endocrine Society” This study found that certain CYP21A2 mutations significantly reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia phenotypes, which may aid in enhancing diagnosis and treatment strategies.
March 2007 in “Journal of Obstetrics and Gynaecology Canada” This review discusses the diagnosis and treatment of hyperandrogenism in women, emphasizing that cyproterone acetate is effective for severe hirsutism, though it reports no new clinical findings.
February 2025 in “Indus journal of bioscience research.” In this descriptive cross-sectional study, researchers observed that cutaneous manifestations such as hirsutism, acne, and androgenic alopecia are common in women with PCOS, with obesity significantly worsening hirsutism, highlighting the importance of early dermatological assessment for PCOS diagnosis and management.
2 citations
,
February 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” In this study, researchers found that correcting the HGPS mutation with Adenine base editing partially rescued accelerated skin cell differentiation and reduced cell death in patient-derived stem cells.
September 2017 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings” This case report suggests that in African-American patients, the histology of Central Centrifugal Cicatricial Alopecia may resemble lichen planopilaris, indicating a potential diagnostic challenge.
January 2016 in “cIRcle (University of British Columbia)” This literature review discusses the need for a clinical practice guideline to help Canadian Nurse Practitioners in diagnosing and managing PCOS, noting its complexity and lack of existing guidelines.
75 citations
,
June 1999 in “Pediatric Clinics of North America” This review discusses the clinical features and therapeutic goals for teenagers with PCOS, emphasizing the need for further research into its causes and potential long-term health risks, but reports no new clinical results.
1 citations
,
October 2022 in “Curēus” This case report highlights the challenges in diagnosing simple-virilizing congenital adrenal hyperplasia, emphasizing the importance of early expert evaluation to prevent irreversible changes such as virilization.
December 2016 in “Asian Pacific journal of cancer biology” This paper discusses the importance of early diagnosis and treatment of polycystic ovarian syndrome to potentially reduce long-term complications like diabetes, hypertension, and heart disease, but reports no new clinical outcomes.
4 citations
,
October 2023 in “Journal of clinical medicine” This meta-analysis found that women with polycystic ovary syndrome have over a 2.5-fold higher risk of depression compared to healthy women.
April 2025 in “Digital Commons - East Tennessee State University (East Tennessee State University)” This study reviewed recent literature on Long COVID, examining cardiopulmonary, dermatological, neurological, and rheumatological symptoms and identifying risk factors like severe initial infection, comorbidities, and lack of prior vaccination.
In this study, only a small percentage of women with polycystic ovary syndrome reported using holistic management strategies, highlighting a need for increased focus on comprehensive approaches to managing the condition.
June 2023 in “Medicine and Pharmacy Reports” A woman with a specific mutation causing adrenal gland issues faced fertility problems, but careful hormone therapy helped her manage it successfully.
May 2025 in “The Journal of Rheumatology” This case report highlights a rare instance of diffuse alveolar hemorrhage in a patient with catastrophic antiphospholipid syndrome, emphasizing the importance of early recognition and multidisciplinary management.
March 2025 in “Journal of Drugs in Dermatology” This study developed a physician-guided algorithm to manage cutaneous adverse events from hormonal therapy in cancer patients, aiming to reduce treatment interruptions and enhance quality of life.
July 2025 in “International Journal of Homoeopathic Sciences” This study suggests that homeopathic treatments may significantly improve menstrual regularity, reduce cystic formations, and enhance the overall quality of life for women with polycystic ovarian disease, indicating its potential as a complementary therapy in gynecological care.
This article discusses the challenges in diagnosing and treating polycystic ovary syndrome in adolescents, emphasizing the importance of lifestyle changes and a systematic therapeutic approach but reports no new clinical findings.
May 2026 in “International Journal of Pharmaceutical Quality Assurance” This study reported that among 95 women with polycystic ovarian syndrome at a tertiary care hospital in India, menstrual irregularities were the most common issue, affecting 86.3% of participants, with many also experiencing hyperandrogenic symptoms, obesity, and infertility.
10 citations
,
June 2010 in “Fertility and Sterility” In this study, patients with polycystic ovary syndrome self-reported higher hirsutism scores compared to clinician assessments, but only clinician scores correlated with biochemical markers of hyperandrogenism.
August 2020 in “Research Square (Research Square)” This study found that young females in Punjab, Pakistan, showed increased prevalence of PCOS symptoms, yet most were unaware of PCOS, suggesting a need for enhanced educational efforts.
11 citations
,
June 2019 in “International journal of gynaecology and obstetrics” This study found that among women with PCOS in Haryana, a larger proportion lived in urban areas, suggesting lifestyle and dietary factors may influence prevalence.